Innovmab Therapeutics

Innovmab Therapeutics is a company driven by omics big data to develop targeted drugs and novel precision medical decision-making tools. Based on proteomics technology and various highly clinically relevant disease model libraries such as PDX/PDO, the company has established a unique drug R&D decision-making tool platform. By leveraging highly clinically relevant big data and deep biological insights obtained through AI computation, it promotes the high success rate development of its self-developed new drug pipelines and IVD products. This technology platform can provide rational decision-making data support for multiple key stages of new drug development, including target discovery, drug mechanism of action, patient selection, clinical trial design, determination of interim/surrogate endpoints in clinical studies, combination therapy development, clinical medication decision support, and drug indication expansion.